235 related articles for article (PubMed ID: 35982398)
1. The expression of Hexokinase 2 and its hub genes are correlated with the prognosis in glioma.
Huang Y; Ouyang F; Yang F; Zhang N; Zhao W; Xu H; Yang X
BMC Cancer; 2022 Aug; 22(1):900. PubMed ID: 35982398
[TBL] [Abstract][Full Text] [Related]
2. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
3. miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma Cells.
Kim J; Park MW; Park YJ; Ahn JW; Sim JM; Kim S; Heo J; Jeong JH; Lee M; Lim J; Moon JS
Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33922649
[TBL] [Abstract][Full Text] [Related]
4. [Increased TRIM5 is associated with a poor prognosis and immune infiltration in glioma patients].
Chen Y; Li Q; Zhang J; Gu R; Li K; Zhao G; Yuan H; Feng T; Ou D; Lin P
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Jun; 37(3):469-479. PubMed ID: 32597089
[TBL] [Abstract][Full Text] [Related]
5. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.
Zhong J; Xiang D; Ma X
Biomed Res Int; 2022; 2022():2309339. PubMed ID: 35845958
[TBL] [Abstract][Full Text] [Related]
6. Integrated machine learning methods identify FNDC3B as a potential prognostic biomarker and correlated with immune infiltrates in glioma.
Wang X; Huang Y; Li S; Zhang H
Front Immunol; 2022; 13():1027154. PubMed ID: 36275754
[TBL] [Abstract][Full Text] [Related]
7. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
[TBL] [Abstract][Full Text] [Related]
8. Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme.
Wolf A; Agnihotri S; Munoz D; Guha A
Neurobiol Dis; 2011 Oct; 44(1):84-91. PubMed ID: 21726646
[TBL] [Abstract][Full Text] [Related]
9. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme.
Ye Y; Zhong W; Qian J; Zhang J; Xu T; Han R; Han J; Wang C; Song L; Zeng X; Wang H
Front Cell Dev Biol; 2023; 11():1042490. PubMed ID: 36711038
[No Abstract] [Full Text] [Related]
11. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma.
Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L
Front Oncol; 2022; 12():1004324. PubMed ID: 36465369
[TBL] [Abstract][Full Text] [Related]
12. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
Front Immunol; 2022; 13():899710. PubMed ID: 35677036
[TBL] [Abstract][Full Text] [Related]
13. Hexokinase 2 (HK2), the tumor promoter in glioma, is downregulated by miR-218/Bmi1 pathway.
Liu H; Liu N; Cheng Y; Jin W; Zhang P; Wang X; Yang H; Xu X; Wang Z; Tu Y
PLoS One; 2017; 12(12):e0189353. PubMed ID: 29220380
[TBL] [Abstract][Full Text] [Related]
14. PANX2 and brain lower grade glioma genesis: A bioinformatic analysis.
Xu X; Hao Y; Xiong S; He Z
Sci Prog; 2021; 104(2):368504211011836. PubMed ID: 33913372
[TBL] [Abstract][Full Text] [Related]
15. The Prognostic Role of Glutathione Peroxidase 1 and Immune Infiltrates in Glioma Investigated Using Public Datasets.
Lv S; Luo H; Huang K; Zhu X
Med Sci Monit; 2020 Oct; 26():e926440. PubMed ID: 33085656
[TBL] [Abstract][Full Text] [Related]
16. S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma.
Zhang Y; Yang X; Zhu XL; Bai H; Wang ZZ; Zhang JJ; Hao CY; Duan HB
Aging (Albany NY); 2021 Jun; 13(11):15459-15478. PubMed ID: 34148033
[TBL] [Abstract][Full Text] [Related]
17. A Novel TAF-Related Signature Based on ECM Remodeling Genes Predicts Glioma Prognosis.
Wang LJ; Lv P; Lou Y
Front Oncol; 2022; 12():862723. PubMed ID: 35574375
[TBL] [Abstract][Full Text] [Related]
18. HOTAIR/miR-125 axis-mediated Hexokinase 2 expression promotes chemoresistance in human glioblastoma.
Zhang J; Chen G; Gao Y; Liang H
J Cell Mol Med; 2020 May; 24(10):5707-5717. PubMed ID: 32279420
[TBL] [Abstract][Full Text] [Related]
19. Co-amplified with PDGFRA, IGFBP7 is a prognostic biomarker correlated with the immune infiltrations of glioma.
Wang H; Wang X; Xu L; Zhang J
Cancer Med; 2023 Feb; 12(4):4951-4967. PubMed ID: 36043552
[TBL] [Abstract][Full Text] [Related]
20. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]